News

Miraculin is a naturally occurring glycoprotein derived from the miracle fruit (Synsepalum dulcificum) that has garnered significant scientific interest due to its unique ability to modify taste ...
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
BROOKLYN, N.Y.--(BUSINESS WIRE)--Accutar Biotechnology, Inc., a biotechnology company focusing on artificial intelligence (AI)-enabled drug discovery, today announced that the U.S. Food and Drug ...
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the ...
For a long time, humans have used medicinal plants for therapeutic purposes and in food and other industries. Classical biotechnology techniques have been exploited in breeding medicinal plants. Now, ...
Our faculty are founders or members of a number of interdisciplinary research centers and labs, which serve as nexuses between academia, industry and public research. The BioFrontiers Institute, ...
Brewer's yeast (Saccharomyces cerevisiae) is a cornerstone of industrial biotechnology. Its exceptional adaptability to diverse natural and industrial environments has led to the emergence of a wide ...
Microalgae are a highly diverse group of unicellular organisms comprising the eukaryotic protists and the prokaryotic cyanobacteria or blue-green algae. The microalgae have a unique environmental ...
Anbio Biotechnology (NASDAQ:NNNN) has filed to raise $8.8 million in an IPO of its Class A ordinary shares, according to an SEC F-1 registration statement. NNNN provides in vitro diagnostics products ...
First patient enrolled in ECLIPSE 2 Phase 3 clinical trial evaluating the switch to the combination of tobevibart and elebsiran in patients not achieving undetectable hepatitis delta virus RNA despite ...